MRD Testing Market is Expected to Reach $6.67 Billion by 2033: BIS Research

The global MRD testing market is rapidly expanding, fueled by the need for precise cancer monitoring methods. Technologies like PCR, NGS, and flow cytometry detect and quantify minimal residual disease (MRD) in cancer patients, guiding treatment decisions and prognostic assessments. 

The MRD testing market offers significant opportunities for diagnostic firms, pharmaceutical companies, and research institutions to innovate and improve patient outcomes. MRD testing is crucial for identifying residual cancer cells post-treatment, enhancing early detection, and personalized treatments. 

Collaborations between companies like Providence and GRAIL aim to broaden access to screening, while acquisitions, such as IDT acquiring ArcherDX assays, signify industry commitment to advancing oncology research solutions. 

Recently, BIS Research released the MRD (Minimal Residual Disease) Testing Market Report, which spans from 2022 to 2033, forecasting substantial growth. In 2023, the market size stood at $1.67 billion, projected to be $6.67 billion by 2033, indicating a notable CAGR of 14.81%. The report, comprising 202 pages, includes 16 tables and 148 figures, offering comprehensive insights into the market dynamics and trends. 

Access Insights: MRD Testing Market 

USP and Key Highlights of the Report  

• A dedicated section focusing on the trends adopted by the key players operating in the MRD testing market 
• Company profile of the companies operating in the ecosystem offering a holistic view of the MRD testing market landscape.  
• Qualitative and quantitative analysis of the MRD testing market 
• Supply chain and value chain analysis  

Strategic Growth Initiatives: Offering insights into successful growth strategies such as mergers, acquisitions, and partnerships, the report can guide your organization in crafting compelling marketing and expansion strategies to solidify its market position.  

Competitive Landscape Analysis: By profiling key players and examining their strategies, the report gives a clear view of the competitive environment, enabling your organization to benchmark its practices and uncover strategic alliances or innovation opportunities.  

Identification of Untapped Markets: By exploring partnerships, agreements, and collaborations among key market players, the report illuminates untapped revenue pockets and emerging market opportunities, guiding your organization toward profitable ventures.    

View Report Pricing 

MRD Testing Market Analysis: Drivers, Challenges, and Opportunities 

Market Demand Drivers: 

•  Advent of MRD testing and its awareness among consumers 

•  Increasing incidence of cancer cases demanding MRD testing  

•  Expanding medicare coverage for MRD testing 

•  Rise in the administration of solid tumor diagnosis in the MRD testing ecosystem 

Market Challenges: 

•  Substantially high cost of MRD tests 

•  Early risk of progression and relapse due to MRD negative result 

Market Opportunities:  

•  Advancements in the development of companion diagnostics 

•  Rising number of clinical trials in prolonged MRD-negative treatment decisions 

Download Complete TOC    

MRD Testing Market Segments 

Segmentation 1: by Technology  

•  Flow Cytometry 

•  Polymerase Chain Reaction (PCR) 

•  Next-Generation Sequencing (NGS) 

•  Other Technologies 

Segmentation 2: by Target Detection 

•   Solid Tumor 

•   Leukemia 

•   Lymphoma 

Segmentation 3: by End User  

•  Hospitals and Speciality Clinics  

•  Research Institutions  

•  Diagnostic Laboratories  

•  Other End Users 

Segmentation 4: by Region 

•  North America - U.S. and Canada 

•  Europe - Germany, France, U.K., Italy, Spain, and Rest-of-Europe  

•  Asia-Pacific - China, India, Japan, South Korea, Australia, Singapore, and Rest-of-Asia-Pacific 

•  Latin America - Brazil, Mexico, Saudi Arabia, Rest-of-Latin America, and Middle East 

•  Rest-of-the-World (RoW)  

Overview: The global MRD testing market is segmented by technology, target detection, end user, and region. Flow cytometry leads in technology, driven by innovations like multiparametric assays. Leukemia dominates target detection, comprising 52.71% of the market. Hospitals and specialty clinics witness significant growth in providing MRD testing kits and services. China dominates the Asia-Pacific market in the region segment, driven by rising cancer cases and health awareness. 

Access Free Sample Report (Including Full TOC, List of Tables, Figures, and Chart)              

Key Players in the MRD Testing Market 

•   Adaptive Biotechnologies 

•   Laboratory Corporation of America Holdings 

•   NeoGenomics Laboratories, Inc. 

•   Quest Diagnostics Incorporated  

•   QIAGEN N.V. 

•   Thermo Fisher Scientific, Inc.  

•   Sysmex Corporation 

•   Mission Bio, Inc.  

•   OPKO Health, Inc. 

•   Bio-Rad Laboratories, Inc. 

•   ICON plc 

•   F. Hoffmann-La Roche Ltd 

•   Invivoscribe, Inc. 

•   ARUP Laboratories 

•   Guardant Health, Inc. 

Schedule a Call with Industry Experts 

Other Related Reports from BIS Healthcare 

Synthetic Hormones Market 

Clinical Biomarkers Market 

Highly Potent API Market 

Korea Centrifugation Market 

Digital Therapeutics Market 

Global Particle Therapy Market 

About BIS Research 

BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends, which can disrupt the market dynamics in the near future. We publish over 200 market intelligence studies annually, focusing on several deep technology verticals.   

Our strategic market analysis emphasizes market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.    

BIS Research offers syndicate and custom studies and expert consultations to firms, providing them with specific and actionable insights on novel technology markets, business models, and competitive landscapes.   

Contact 

Head of Marketing   

Email: media@bisresearch.com    

BIS Research Inc.   

39111 PASEO PADRE PKWY STE 313,   

FREMONT, CA 94538-1686   

Visit our Blog @https://bisresearch.com/insights   

Get Expert Insights @https://community.insightmonk.com    

Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research    

Connect with us on Twitter@ https://twitter.com/BISResearch